Dalhousie University’s Faculty of Medicine invites applications for a tenure stream position as a Tier 1 Canada Research Chair (CRC) in Translational Immunology and Vaccinology at the level of Associate or Full Professor. The successful candidate will join a vibrant and productive community of clinicians, basic and social scientists and research trainees with interests in vaccine discovery, immunology/inflammation, epidemiology, clinical trials, and health policy. Applicants with an MD or Ph.D. conducting research in the area of translational immunology and vaccinology will be considered for this CRC position. The ideal candidate will have a strong track record of innovative research in vaccinology, vaccine or translational immunology or related research areas, such as knowledge translation. Evidence of effective participation in interdisciplinary research teams and trainee supervision will be an asset. The candidate must have the potential to develop a collaborative research program that is complementary to ongoing research activities in vaccinology and immunology within Dalhousie University, and to engage with local, national and international research networks.
The successful candidate will join the Canadian Center for Vaccinology and the Dalhousie Inflammation Group. Ongoing basic and translational studies include the regulation of human immunology related to autoimmunity, host-pathogen interactions, inflammatory disease, adjuvants and novel vaccine delivery mechanisms, and the host response to immunization. Multiple clinical trials are underway including phase 1 studies of candidate influenza vaccines, RSV vaccines, group A streptococcal vaccine, and CMV vaccine. Dalhousie is the host institution for the Canada Immunization Research Network (CIRN) with its broad mandate for undertaking research to inform public health decision-making. Health policy research includes work in bioethics, health law, and interdisciplinary quantitative and qualitative studies addressing vaccine uptake and vaccine hesitancy. Core facilities for research include excellent flow cytometry, proteomics, sequencing and imaging units, and data management and statistical support. Dalhousie University is located in the friendly, vibrant, ocean side city of Halifax, Nova Scotia. The city and surrounding area have a wide range of cultural activities and opportunities. Excellent schools, sports facilities and outdoor activities are also available locally.
The CRC program was established by the Canadian Federal Government with the purpose of attracting outstanding researchers to the Canadian university system. Tier 1 CRC chairs must be outstanding and innovative world-class researchers whose accomplishments have made a major impact in their fields and be recognized internationally as leaders in their fields. The program’s full Terms of Reference for qualifications are online at www.chairs.gc.ca. Appointment to this Canada Research Chair position is subject to review and final approval by the Canada Research Chair Secretariat.
The application deadline is March 30th, 2017. A complete application must include a curriculum vitae, a 2 page research statement, a 1 page description of student supervisory experience, a completed Self-Identification Questionnaire, which is available at www.dal.ca/becounted/selfid and arrange to have 3 letters of reference sent under separate cover directly to Drs. Jean Marshall and Scott Halperin, Co-Chairs of the Search and Selection Committee c/o Kelly LeFurgey, Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, 5850/5980 University Ave, Halifax, NS B3K 6R8. E-mail: Kelly.LeFurgey(at)iwk.nshealth.ca
Dalhousie University is committed to fostering a collegial culture grounded in diversity and inclusiveness. The university encourages applications from Aboriginal people, persons with a disability, racially visible persons, women, persons of minority sexual orientations and gender identities, and all candidates who would contribute to the diversity of our community.
Start date: between Feb 2016 – Apr 2016
Cancer Research Centre of Marseille (CRCM)
The Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille) affiliated to Inserm (UMR1068), CNRS (UMR7258) and Aix-Marseille University (UM105), located on the seacoast in beautiful Provence, is an original center in the landscape of French research. This originality is not only due to its location in the heart of the Institut Paoli-Calmettes (IPC) but also to its vocation: to advance the biology and medicine of cancer while working at the physiological and pathological interface, the fundamental and the applied, research and the clinic. This continuum between basic research, translational research and clinical research is really the hallmark of the CRCM. All seminars at the institute are held in English and the working environment is bilingual (French/English). Salaries are based on Inserm guidelines taking into account years of experience.
The CRCM has more than 250 staff including 17 research teams, administration and technical services. In addition to the medical imaging platform, the pathobiology laboratory and the tumour bank of the institute, they have access, on site or nearby, to all technologies that contribute to the discovery and development of biomarkers and new therapeutic targets: genomics (including NGS), proteomics, cell imaging in vitro and in vivo immunomonitoring, bioinformatics and biostatistics.
We are looking for a competitive and dynamic post doc to study the influence of epigenetic deregulation in the context of hematopoiesis. Our particular focus is the oncogenic cooperation between receptor tyrosine kinases and epi-regulators that are mutated in mastocytosis, and the molecular mechanisms that govern these interactions. We have generated molecular tools as well as animal models (KI, KO, Tg) to study such mechanisms in primary cells. We are seeking applicants with a scientific and technical background in molecular cell biology, NGS and proteomic approaches to study epigenetics, transcription factor complexes and their effects on gene regulation in this context. A background in immune cell signalling pathways and familiarity with R/R-studio for data analysis would be an advantage.
Closing date: 30th January, 2016